Global Malaria Diagnostics Market

Malaria Diagnostics Comprehensive Study by Type (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests (Conventional PCR, Real-Time PCR (quantitative PCR or qPCR))), End User (Clinics, Hospitals, Laboratories, Others) Players and Region - Global Market Outlook to 2030

Malaria Diagnostics Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Malaria Diagnostics
Growing demand for diagnostics in malaria-endemic countries and innovation of novel diagnostic techniques will help to boost global malaria diagnosis market. Malaria is a type of disease caused by the Plasmodium parasites and is spread by the female Anopheles mosquito. Diagnosis of malaria contains recognition by microscopy and blood tests. Rising occurrence of drug-resistant strains of parasites, increasing incidence of malaria, huge upsurges in international travel and government initiatives in awareness as well as diagnostic programs. This is act as a major driver of malaria diagnosis market.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia- Pacific
UnitValue (USD Million)
CAGR4.5%


The global malaria diagnostics market appears to be moderately fragmented and with the presence of several companies. This market research report will help customers identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Malaria Diagnostics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Laboratories (United States), Premier Medical Corporation Pvt. Ltd. (India), Sysmex Partec GmbH (Germany), bioMérieux (France), Beckman Coulter Inc. (United States), Novartis (Switzerland), Siemens Healthineers (Germany), Leica Microsystems GmbH (Germany), Nikon Corporation (Japan) and Olympus Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Bio-Rad Laboratories, Inc. (United States) and Ortho- Clinical Diagnostics (United States).

Segmentation Overview
AMA Research has segmented the market of Global Malaria Diagnostics market by Type (Microscopy, Rapid Diagnostic Tests and Molecular Diagnostic Tests [Conventional PCR, Real-Time PCR (quantitative PCR or qPCR)]) and Region.



On the basis of geography, the market of Malaria Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by End User, the sub-segment i.e. Clinics will boost the Malaria Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Demand Due To Rapid Diagnostic Tests (Rdts) and Increasing Investments by Government and Private Investors

Market Growth Drivers:
Up Surging Demand for Diagnostics Methods, Intensifying Cases of Tropical Diseases and Growths in Diagnostic Techniques

Challenges:
Strict Government Regulation for Drug Approvals

Restraints:
Accelerating The Acceptance Of Diagnostic Tests

Opportunities:
Growing Demand Due To Technological Advancements in Emerging Countries

Market Leaders and their expansionary development strategies
In July 2021, The new Partnership for Vivax Elimination (PAVE) launched to support countries in the elimination of P. vivax – a complex and persistent type of malaria that poses a risk to more than one-third of the world’s population. The partnership to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide.
Nairobi, Kenya's Ministry of Health launched malaria and Covid PCR diagnostic kits in a bid to boost timely detection and treatment of the two diseases. The kits that are the first to be produced locally.


Key Target Audience
Commercial Research & Development (R&D) Institutions, Associations and Industrial Bodies, Traders, Exporters and Importers, Government Regulatory Bodies, Government and Private Research Institutes and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Microscopy
  • Rapid Diagnostic Tests
  • Molecular Diagnostic Tests [Conventional PCR, Real-Time PCR (quantitative PCR or qPCR)]
By End User
  • Clinics
  • Hospitals
  • Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Up Surging Demand for Diagnostics Methods
      • 3.2.2. Intensifying Cases of Tropical Diseases
      • 3.2.3. Growths in Diagnostic Techniques
    • 3.3. Market Challenges
      • 3.3.1. Strict Government Regulation for Drug Approvals
    • 3.4. Market Trends
      • 3.4.1. Rising Demand Due To Rapid Diagnostic Tests (Rdts)
      • 3.4.2. Increasing Investments by Government and Private Investors
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Malaria Diagnostics, by Type, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Malaria Diagnostics (Value)
      • 5.2.1. Global Malaria Diagnostics by: Type (Value)
        • 5.2.1.1. Microscopy
        • 5.2.1.2. Rapid Diagnostic Tests
        • 5.2.1.3. Molecular Diagnostic Tests [Conventional PCR, Real-Time PCR (quantitative PCR or qPCR)]
      • 5.2.2. Global Malaria Diagnostics by: End User (Value)
        • 5.2.2.1. Clinics
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Laboratories
        • 5.2.2.4. Others
      • 5.2.3. Global Malaria Diagnostics Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Malaria Diagnostics (Price)
      • 5.3.1. Global Malaria Diagnostics by: Type (Price)
  • 6. Malaria Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Premier Medical Corporation Pvt. Ltd. (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sysmex Partec GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BioMérieux (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Beckman Coulter Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novartis (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Siemens Healthineers (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Leica Microsystems GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nikon Corporation (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Olympus Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Malaria Diagnostics Sale, by Type, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Malaria Diagnostics (Value)
      • 7.2.1. Global Malaria Diagnostics by: Type (Value)
        • 7.2.1.1. Microscopy
        • 7.2.1.2. Rapid Diagnostic Tests
        • 7.2.1.3. Molecular Diagnostic Tests [Conventional PCR, Real-Time PCR (quantitative PCR or qPCR)]
      • 7.2.2. Global Malaria Diagnostics by: End User (Value)
        • 7.2.2.1. Clinics
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Laboratories
        • 7.2.2.4. Others
      • 7.2.3. Global Malaria Diagnostics Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Malaria Diagnostics (Price)
      • 7.3.1. Global Malaria Diagnostics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Malaria Diagnostics: by Type(USD Million)
  • Table 2. Malaria Diagnostics Microscopy , by Region USD Million (2018-2023)
  • Table 3. Malaria Diagnostics Rapid Diagnostic Tests , by Region USD Million (2018-2023)
  • Table 4. Malaria Diagnostics Molecular Diagnostic Tests [Conventional PCR, Real-Time PCR (quantitative PCR or qPCR)] , by Region USD Million (2018-2023)
  • Table 5. Malaria Diagnostics: by End User(USD Million)
  • Table 6. Malaria Diagnostics Clinics , by Region USD Million (2018-2023)
  • Table 7. Malaria Diagnostics Hospitals , by Region USD Million (2018-2023)
  • Table 8. Malaria Diagnostics Laboratories , by Region USD Million (2018-2023)
  • Table 9. Malaria Diagnostics Others , by Region USD Million (2018-2023)
  • Table 10. South America Malaria Diagnostics, by Country USD Million (2018-2023)
  • Table 11. South America Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 12. South America Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 13. Brazil Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 14. Brazil Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 15. Argentina Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 16. Argentina Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 17. Rest of South America Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 18. Rest of South America Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 19. Asia Pacific Malaria Diagnostics, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 21. Asia Pacific Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 22. China Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 23. China Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 24. Japan Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 25. Japan Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 26. India Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 27. India Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 28. South Korea Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 29. South Korea Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 30. Taiwan Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 31. Taiwan Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 32. Australia Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 33. Australia Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 36. Europe Malaria Diagnostics, by Country USD Million (2018-2023)
  • Table 37. Europe Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 38. Europe Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 39. Germany Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 40. Germany Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 41. France Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 42. France Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 43. Italy Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 44. Italy Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 45. United Kingdom Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 46. United Kingdom Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 47. Netherlands Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 48. Netherlands Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 49. Rest of Europe Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 50. Rest of Europe Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 51. MEA Malaria Diagnostics, by Country USD Million (2018-2023)
  • Table 52. MEA Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 53. MEA Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 54. Middle East Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 55. Middle East Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 56. Africa Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 57. Africa Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 58. North America Malaria Diagnostics, by Country USD Million (2018-2023)
  • Table 59. North America Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 60. North America Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 61. United States Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 62. United States Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 63. Canada Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 64. Canada Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 65. Mexico Malaria Diagnostics, by Type USD Million (2018-2023)
  • Table 66. Mexico Malaria Diagnostics, by End User USD Million (2018-2023)
  • Table 67. Malaria Diagnostics: by Type(USD/Units)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Malaria Diagnostics: by Type(USD Million)
  • Table 79. Malaria Diagnostics Microscopy , by Region USD Million (2025-2030)
  • Table 80. Malaria Diagnostics Rapid Diagnostic Tests , by Region USD Million (2025-2030)
  • Table 81. Malaria Diagnostics Molecular Diagnostic Tests [Conventional PCR, Real-Time PCR (quantitative PCR or qPCR)] , by Region USD Million (2025-2030)
  • Table 82. Malaria Diagnostics: by End User(USD Million)
  • Table 83. Malaria Diagnostics Clinics , by Region USD Million (2025-2030)
  • Table 84. Malaria Diagnostics Hospitals , by Region USD Million (2025-2030)
  • Table 85. Malaria Diagnostics Laboratories , by Region USD Million (2025-2030)
  • Table 86. Malaria Diagnostics Others , by Region USD Million (2025-2030)
  • Table 87. South America Malaria Diagnostics, by Country USD Million (2025-2030)
  • Table 88. South America Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 89. South America Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 90. Brazil Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 91. Brazil Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 92. Argentina Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 93. Argentina Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 94. Rest of South America Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 95. Rest of South America Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 96. Asia Pacific Malaria Diagnostics, by Country USD Million (2025-2030)
  • Table 97. Asia Pacific Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 98. Asia Pacific Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 99. China Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 100. China Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 101. Japan Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 102. Japan Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 103. India Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 104. India Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 105. South Korea Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 106. South Korea Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 107. Taiwan Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 108. Taiwan Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 109. Australia Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 110. Australia Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 111. Rest of Asia-Pacific Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 112. Rest of Asia-Pacific Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 113. Europe Malaria Diagnostics, by Country USD Million (2025-2030)
  • Table 114. Europe Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 115. Europe Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 116. Germany Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 117. Germany Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 118. France Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 119. France Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 120. Italy Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 121. Italy Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 122. United Kingdom Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 123. United Kingdom Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 124. Netherlands Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 125. Netherlands Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 126. Rest of Europe Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 127. Rest of Europe Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 128. MEA Malaria Diagnostics, by Country USD Million (2025-2030)
  • Table 129. MEA Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 130. MEA Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 131. Middle East Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 132. Middle East Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 133. Africa Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 134. Africa Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 135. North America Malaria Diagnostics, by Country USD Million (2025-2030)
  • Table 136. North America Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 137. North America Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 138. United States Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 139. United States Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 140. Canada Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 141. Canada Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 142. Mexico Malaria Diagnostics, by Type USD Million (2025-2030)
  • Table 143. Mexico Malaria Diagnostics, by End User USD Million (2025-2030)
  • Table 144. Malaria Diagnostics: by Type(USD/Units)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Malaria Diagnostics: by Type USD Million (2018-2023)
  • Figure 5. Global Malaria Diagnostics: by End User USD Million (2018-2023)
  • Figure 6. South America Malaria Diagnostics Share (%), by Country
  • Figure 7. Asia Pacific Malaria Diagnostics Share (%), by Country
  • Figure 8. Europe Malaria Diagnostics Share (%), by Country
  • Figure 9. MEA Malaria Diagnostics Share (%), by Country
  • Figure 10. North America Malaria Diagnostics Share (%), by Country
  • Figure 11. Global Malaria Diagnostics: by Type USD/Units (2018-2023)
  • Figure 12. Global Malaria Diagnostics share by Players 2023 (%)
  • Figure 13. Global Malaria Diagnostics share by Players (Top 3) 2023(%)
  • Figure 14. Global Malaria Diagnostics share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 18. Premier Medical Corporation Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 19. Premier Medical Corporation Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 20. Sysmex Partec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Sysmex Partec GmbH (Germany) Revenue: by Geography 2023
  • Figure 22. BioMérieux (France) Revenue, Net Income and Gross profit
  • Figure 23. BioMérieux (France) Revenue: by Geography 2023
  • Figure 24. Beckman Coulter Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Beckman Coulter Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Novartis (Switzerland) Revenue: by Geography 2023
  • Figure 28. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Siemens Healthineers (Germany) Revenue: by Geography 2023
  • Figure 30. Leica Microsystems GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Leica Microsystems GmbH (Germany) Revenue: by Geography 2023
  • Figure 32. Nikon Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Nikon Corporation (Japan) Revenue: by Geography 2023
  • Figure 34. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Olympus Corporation (Japan) Revenue: by Geography 2023
  • Figure 36. Global Malaria Diagnostics: by Type USD Million (2025-2030)
  • Figure 37. Global Malaria Diagnostics: by End User USD Million (2025-2030)
  • Figure 38. South America Malaria Diagnostics Share (%), by Country
  • Figure 39. Asia Pacific Malaria Diagnostics Share (%), by Country
  • Figure 40. Europe Malaria Diagnostics Share (%), by Country
  • Figure 41. MEA Malaria Diagnostics Share (%), by Country
  • Figure 42. North America Malaria Diagnostics Share (%), by Country
  • Figure 43. Global Malaria Diagnostics: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Premier Medical Corporation Pvt. Ltd. (India)
  • Sysmex Partec GmbH (Germany)
  • bioMérieux (France)
  • Beckman Coulter Inc. (United States)
  • Novartis (Switzerland)
  • Siemens Healthineers (Germany)
  • Leica Microsystems GmbH (Germany)
  • Nikon Corporation (Japan)
  • Olympus Corporation (Japan)
Additional players considered in the study are as follows:
Bio-Rad Laboratories, Inc. (United States) , Ortho- Clinical Diagnostics (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 234 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Malaria Diagnostics Market Quantitative research analysis
Global Malaria Diagnostics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Laboratories (United States), Premier Medical Corporation Pvt. Ltd. (India), Sysmex Partec GmbH (Germany), bioMérieux (France), Beckman Coulter Inc. (United States), Novartis (Switzerland), Siemens Healthineers (Germany), Leica Microsystems GmbH (Germany), Nikon Corporation (Japan) and Olympus Corporation (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Demand Due To Rapid Diagnostic Tests (Rdts) " is seen as one of major influencing trends for Malaria Diagnostics Market during projected period 2023-2030.
The Malaria Diagnostics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Malaria Diagnostics Market Report?

Have a Query? Click Here

Other Related Reports

Minimally Invasive Surgery Comprehensive Study by Type (Endoscopic Devices, Electrosurgical Devices, Monitoring and Visualization Devices), Application (Cosmetic Surgery, Cardiac Surgery, Gastrointes...
$ 3650
Therapeutic Drug Monitoring Comprehensive Study by Type (Consumable, Equipment (Immunoassay analyzer)), Application (Hospitals (Clinical Pharmacology departments), Pathological labs, Research and Aca...
$ 3750
Digital Therapeutics Comprehensive Study by Disease (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Disease, Gastrointestinal Disorders (GID), Respiratory Diseases, Sm...
$ 3650
Kidney Fibrosis Treatment Comprehensive Study by Therapeutics (Angiotensin Converting Enzyme (ACE) Inhibitors, Pirfenidone, Renin Inhibitors, Angiotensin II Receptor Blockers (ARBs), Vasopeptidase In...
$ 3350
Legionella Testing Comprehensive Study by Type (Microbial Culture, DFA Stain, PCR, Others), Application (Water Testing, IVD Testing), End User (Hospital and Clinic, Diagnostic Laboratory) Players and...
$ 3500
Chemotherapy Induced Peripheral Neuropathy Treatment Comprehensive Study by Type (APX-3330, BR-297, Cannabidiol, Dimiracetam, Others), Application (Platinum Agents, Taxanes, Vinca Alkaloids, Others) ...
$ 3500